1 finding
“The combination of IL-17 A and CTCs achieved an AUC of 0.953, with a sensitivity of 86.05% and specificity of 90.00%.”
Associations
1Non-small cell lung cancer
upin humans1
1 study
Non-small cell lung cancer
upin humans1
IL-17A + CTCs predicts non-small cell lung cancer in humans (diagnosis of early-stage NSCLC) (AUC 0.953, sensitivity 86.05%, specificity 90.00%).
Humansdiagnosis of early-stage NSCLCblood